MT Newswires
Oppenheimer Adjusts Capricor Therapeutics PT to $54 From $22, Maintains Outperform Rating
📊
AI Sentiment
Positive
7/10
- Home
- CAPR
as of 12-12-2025 3:45pm EST
$26.07
$1.11
-4.08%
Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.
Chart Type:
Time Range:
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 324.6M | IPO Year: | N/A |
| Target Price: | $37.75 | AVG Volume (30 days): | 5.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.81 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.30 - $40.37 | Next Earning Date: | 11-10-2025 |
| Revenue: | $11,130,509 | Revenue Growth: | -52.08% |
| Revenue Growth (this year): | -93.89% | Revenue Growth (next year): | 7736.03% |
AI-Powered CAPR Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 72.11%
72.11%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Capricor Therapeutics Inc. News
CAPR Breaking Stock News: Dive into CAPR Ticker-Specific Updates for Smart Investing
Compare CAPR vs Leading Stocks
See how CAPR stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CAPR Capricor Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.